Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,365 | 117 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $792.76 | 34 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $272.74 | 15 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $264.44 | 16 | $0 (2024) |
| VIVUS LLC | $123.25 | 7 | $0 (2024) |
| Ardelyx, Inc. | $118.54 | 5 | $0 (2024) |
| Madrigal Pharmaceuticals | $115.55 | 5 | $0 (2024) |
| INTERCEPT PHARMACEUTICALS, INC. | $106.77 | 6 | $0 (2023) |
| Merck Sharp & Dohme LLC | $106.15 | 6 | $0 (2024) |
| RedHill Biopharma Inc. | $76.40 | 4 | $0 (2022) |
| Nestle HealthCare Nutrition Inc. | $46.59 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $525.56 | 25 | Ardelyx, Inc. ($118.54) |
| 2023 | $214.31 | 11 | Ironwood Pharmaceuticals, Inc ($81.56) |
| 2022 | $355.33 | 19 | Ironwood Pharmaceuticals, Inc ($92.91) |
| 2021 | $360.99 | 20 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($64.06) |
| 2020 | $80.28 | 5 | IRONWOOD PHARMACEUTICALS, INC ($32.29) |
| 2019 | $291.62 | 3 | AbbVie, Inc. ($274.59) |
| 2018 | $178.82 | 12 | AbbVie, Inc. ($126.73) |
| 2017 | $357.77 | 22 | AbbVie, Inc. ($264.37) |
All Payment Transactions
117 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: LIVER DISEASE | ||||||
| 12/10/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: LIVER DISEASE | ||||||
| 11/22/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: LIVER DISEASE | ||||||
| 11/19/2024 | VIVUS LLC | PANCREAZE (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $30.32 | General |
| Category: LIVER DISEASE | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Gastroenterology | ||||||
| 10/15/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/09/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: LIVER DISEASE | ||||||
| 10/01/2024 | VIVUS LLC | PANCREAZE (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/24/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/20/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/15/2024 | Micro-tech Endoscopy USA, Inc. | LesionHunter (Device) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: GI Endoscopy | ||||||
| 08/13/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $15.70 | General |
| Category: GI | ||||||
| 08/06/2024 | VIVUS LLC | PANCREAZE (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Gastroenterology | ||||||
| 07/16/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/09/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/14/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/05/2024 | VIVUS LLC | PANCREAZE (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/31/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $33.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/28/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $21.43 | General |
| Category: GI | ||||||
| 05/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/30/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/09/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 713 | 785 | $1.5M | $87,972 |
| 2022 | 6 | 773 | 868 | $1.9M | $103,103 |
| 2021 | 6 | 878 | 991 | $2.3M | $120,681 |
| 2020 | 6 | 731 | 774 | $1.8M | $97,101 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 00142 | Anesthesia for lens surgery | Facility | 2023 | 303 | 353 | $624,300 | $36,102 | 5.8% |
| 00140 | Anesthesia for other procedure on eye | Facility | 2023 | 153 | 172 | $358,800 | $21,541 | 6.0% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Office | 2023 | 122 | 122 | $255,000 | $14,305 | 5.6% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Office | 2023 | 110 | 111 | $215,100 | $12,428 | 5.8% |
| 00103 | Anesthesia for procedure on eyelid | Facility | 2023 | 25 | 27 | $62,400 | $3,595 | 5.8% |
| 00142 | Anesthesia for lens surgery | Facility | 2022 | 422 | 499 | $1.0M | $52,939 | 5.2% |
| 00140 | Anesthesia for other procedure on eye | Facility | 2022 | 147 | 163 | $396,300 | $21,389 | 5.4% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Office | 2022 | 106 | 106 | $259,800 | $14,180 | 5.5% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Office | 2022 | 66 | 67 | $162,900 | $9,129 | 5.6% |
| 00145 | Anesthesia for retinal surgery | Facility | 2022 | 17 | 17 | $54,300 | $3,082 | 5.7% |
| 00103 | Anesthesia for procedure on eyelid | Facility | 2022 | 15 | 16 | $42,300 | $2,384 | 5.6% |
| 00142 | Anesthesia for lens surgery | Facility | 2021 | 414 | 503 | $1.0M | $53,742 | 5.1% |
| 00140 | Anesthesia for procedure on eye | Facility | 2021 | 174 | 195 | $491,700 | $26,280 | 5.3% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2021 | 150 | 152 | $382,500 | $20,760 | 5.4% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Office | 2021 | 110 | 111 | $278,400 | $15,247 | 5.5% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Office | 2021 | 14 | 14 | $45,000 | $2,358 | 5.2% |
| 00103 | Anesthesia for procedure on eyelid | Facility | 2021 | 16 | 16 | $41,100 | $2,294 | 5.6% |
| 00142 | Anesthesia for lens surgery | Facility | 2020 | 258 | 282 | $608,100 | $30,560 | 5.0% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2020 | 188 | 193 | $468,300 | $25,676 | 5.5% |
| 00140 | Anesthesia for procedure on eye | Facility | 2020 | 119 | 127 | $331,500 | $17,582 | 5.3% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Office | 2020 | 126 | 128 | $302,400 | $16,274 | 5.4% |
| 00910 | Anesthesia for procedure on urinary system including use of an endoscope | Office | 2020 | 26 | 29 | $72,450 | $4,528 | 6.2% |
| 00145 | Anesthesia for retinal surgery | Facility | 2020 | 14 | 15 | $47,100 | $2,481 | 5.3% |
About Dr. Igor Maganov, MD
Dr. Igor Maganov, MD is a Anesthesiology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2008. The National Provider Identifier (NPI) number assigned to this provider is 1902063258.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Igor Maganov, MD has received a total of $2,365 in payments from pharmaceutical and medical device companies, with $525.56 received in 2024. These payments were reported across 117 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,365).
As a Medicare-enrolled provider, Maganov has provided services to 3,095 Medicare beneficiaries, totaling 3,418 services with total Medicare billing of $408,857. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Location Brooklyn, NY
- Active Since 05/22/2008
- Last Updated 03/09/2010
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1902063258
Products in Payments
- Creon (Drug) $374.46
- Linzess (Drug) $272.74
- Mavyret (Drug) $146.76
- XIFAXAN (Drug) $143.46
- Viekira (Drug) $119.47
- IBSRELA (Drug) $118.54
- RESMETIROM (Drug) $115.55
- OCALIVA (Drug) $106.77
- DIFICID (Drug) $90.32
- CREON (Drug) $90.27
- TRULANCE (Drug) $84.71
- Talicia (Drug) $76.40
- XIFAXANIBSD (Drug) $74.65
- PANCREAZE (Drug) $69.30
- Qsymia (Drug) $53.95
- ZENPEP (Drug) $46.59
- STELARA (Biological) $43.45
- LINZESS (Drug) $36.80
- AcrySof (Device) $35.64
- VOQUEZNA (Drug) $23.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Brooklyn
Dr. Mark Kronenfeld, M.d, M.D
Anesthesiology — Payments: $2.5M
Mehrdad Hedayatnia, Md, MD
Anesthesiology — Payments: $27,710
Jason Kreiner, M.d, M.D
Anesthesiology — Payments: $19,382
Roman Shulkin, M.d, M.D
Anesthesiology — Payments: $15,731
Dr. Edwin Perez, M.d, M.D
Anesthesiology — Payments: $11,545
Shaesta Humayun, Md, MD
Anesthesiology — Payments: $7,219